A cohort study finds the risk for acne in patients on JAK inhibitors for atopic dermatitis was about 2.5 times greater than ...

In certain patients, JAK inhibitor rescue medications seem to be more effective, researche ...

Editor's note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. First to, maybe step back and say, what is ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. MIAMI BEACH, Fla. — Janus kinase inhibitors are an ...

Remibrutinib, a BTK inhibitor, offers a new oral treatment for chronic spontaneous urticaria, providing an alternative to traditional therapies. Experts discuss groundbreaking therapies in dermatology ...

JAK inhibitors increased the risk of herpes zoster (HZ) and upper respiratory tract (URT) infections in patients with atopic dermatitis (AD). On subsequent analysis, however, that increase diminished ...

ATI-2138 Outperforms Ritlecitinib in Reversal Model of Alopecia Universalis, the Most Severe AA Phenotype -WAYNE, Pa., (GLOBE ...

Spleen size, blood counts and symptom burden are some of the factors cancer teams take into account when selecting which of the four JAK inhibitors to treat patient with myelofibrosis. Several patient ...

Lynk’s zemprocitinib commercial partner, Simcere, will now continue the JAK inhibitor’s development across China in RA.

Jerry Shapiro, MD, discusses strategies for treating patients with scarring and nonscarring alopecia.

Adverse events profile of novel agents targeting immune checkpoints beyond PD-1/PD-L1 and CTLA-4 in solid tumors: A meta-analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.